Ceftriaxone (250mg) + Tazobactam (31.25mg)
Zifi XP 250 mg/31.25 mg Injection is used in the treatment of bacterial infections.
10 ml in 1 vial
FDC Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Zifi XP 250 mg/31.25 mg Injection is a combination of two medicines: Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Tazobactum is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Zifi XP 250 mg/31.25 mg Injection is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Zifi XP 250 mg/31.25 mg Injection should be used with caution during lactation. Breast feeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Zifi XP 250 mg/31.25 mg Injection may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
There is limited information available on the use of Zifi XP 250 mg/31.25 mg Injection in patients with kidney disease. Please consult your doctor.
Zifi XP 250 mg/31.25 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Zifi XP 250 mg/31.25 mg Injection may be needed. Please consult your doctor.
Dose adjustment of Zifi XP 250 mg/31.25 mg Injection is not recommended in patients with mild to moderate liver disease.
